Benefits of using ecoantibiotics in the treatment of inflammatory diseases of ENT organs

Abstract

Different types of microorganisms can be the causative agents of inflammatory diseases of the respiratory tract and ear of a man. In most patients inflammatory changes in the airways begin with the invasion of respiratory viruses [1–3]. In adverse course of the viral disease activation of endogenous bacterial agents colonizing the mucosa of the respiratory tract or superinfection of pathogenic flora occurs [1, 4]. The inclusion of antimicrobial agents in the scheme of complex therapy of bacterial infections of the respiratory tract and the ear is justified in most clinical cases [4, 7]. An important problem of system etiotropic therapy are adverse drug effects and adverse effects, in particular excess growth of pathogenic bacteria as a result of suppression of obligate microbiota [6, 8].

Keywords

• inflammatory diseases of ent-organs
• antibacterial therapy
• dysbiosis
• ecoantibiotics